Pharmaceutical Drug Safety
作者： Martin Brunner
DOI: 10.1007/978-3-7091-0144-5_18
关键词: Pharmacovigilance 、 Drug treatment 、 Drug reaction 、 Intensive care medicine 、 Drug 、 Pharmaceutical drug 、 Adverse effect 、 Medicine 、 Drug withdrawal 、 Drug development
摘要: The occurrence of sometimes life-threatening adverse drug reactions (ADRs) jeopardizes patients’ health during treatment and additionally imposes an increased financial burden on the healthcare system. withdrawal already marketed drugs because ADRs furthermore erodes public confidence in way are approved. In this chapter evolution current status monitoring systems will be discussed, recent developments pharmacovigilance, science activities relating to detection, assessment, understanding prevention effects or any other medicine-related problem outlined.
springer.com
sci-hub.st 参考文章(26)
R. D. Mann, Prescription-event monitoring—recent progress and future horizons British Journal of Clinical Pharmacology. ,vol. 46, pp. 195- 201 ,(1998) , 10.1046/J.1365-2125.1998.00774.X
Curt D Furberg, Bertram Pitt, Withdrawal of cerivastatin from the world market Trials. ,vol. 2, pp. 205- 207 ,(2001) , 10.1186/CVM-2-5-205
Valeri Craigle, MedWatch: The FDA Safety Information and Adverse Event Reporting Program. Journal of The Medical Library Association. ,vol. 95, pp. 224- 225 ,(2007) , 10.3163/1536-5050.95.2.224
C. Marwick, Bayer is forced to release documents over withdrawal of cerivastatin BMJ. ,vol. 326, pp. 518a- 518 ,(2003) , 10.1136/BMJ.326.7388.518/A
Jason Lazarou, Bruce H. Pomeranz, Paul N. Corey, Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies JAMA. ,vol. 279, pp. 1200- 1205 ,(1998) , 10.1001/JAMA.279.15.1200
Terry A. Jacobson, Statin Safety: Lessons from New Drug Applications for Marketed Statins American Journal of Cardiology. ,vol. 97, ,(2006) , 10.1016/J.AMJCARD.2005.12.009
Kwame N Atuah, Dyfrig Hughes, Munir Pirmohamed, Clinical Pharmacology: Special safety considerations in drug development and pharmacovigilance. Drug Safety. ,vol. 27, pp. 535- 554 ,(2004) , 10.2165/00002018-200427080-00006
Munir Pirmohamed, Sally James, Shaun Meakin, Chris Green, Andrew K Scott, Thomas J Walley, Keith Farrar, B Kevin Park, Alasdair M Breckenridge, Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients BMJ. ,vol. 329, pp. 15- 19 ,(2004) , 10.1136/BMJ.329.7456.15
A.M. Bal, The echinocandins: three useful choices or three too many? International Journal of Antimicrobial Agents. ,vol. 35, pp. 13- 18 ,(2010) , 10.1016/J.IJANTIMICAG.2009.09.011
Lesley Wise, John Parkinson, June Raine, Alasdair Breckenridge, New approaches to drug safety: a pharmacovigilance tool kit Nature Reviews Drug Discovery. ,vol. 8, pp. 779- 782 ,(2009) , 10.1038/NRD3002